Billionaire Stanley Druckenmiller Invests 3387 Million in Caris Life Sciences During Q1 TAOP Q2 2011 Earnings EPS Misses Estimates but Stock Rallies 881 European Shares Edge Higher Amid Hopes for USIran Diplomatic Breakthrough Standard Chartered to Reduce Corporate Functions Roles by Over 15 in Push for Higher Returns Catalyst Pharmaceuticals Q1 2026 Earnings EPS Surpasses Estimates by 75 TROW Q1 2026 Earnings Strong EPS Beat Amid Quiet Markets